Erratum: A novel anticancer effect of garlic derivatives: Inhibition of cancer cell invasion through restoration of E-cadherin expression (Carcinogenesis (2007) vol. 27 (11) doi:10.1093/carcin/bgl054);A novel anticancer effect of garlic derivatives: Inhibition of cancer cell invasion through restoration of E-cadherin expression

Carcinogenesis

Volumn 27, Issue 11, 2006, Pages 2180-2189

  Chu, Qingjun ^a   Ling, Ming Tat ^a   Feng, Huichen ^a   Cheung, Hiu Wing ^a   Tsao, Sai Wah ^a   Wang, Xianghong ^a   Wong, Yong Chuan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYSTEINE DERIVATIVE; GARLIC EXTRACT; MATRIGEL; S ALLYLCYSTEINE; S ALLYLMERCAPTOCYSTEINE; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; WATER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER MORTALITY; CELL ASSAY; CELL PROLIFERATION; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; EPITHELIUM CELL; ESOPHAGUS CARCINOMA; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; MESENCHYME CELL; METASTASIS POTENTIAL; NASOPHARYNX CANCER; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WOUND CLOSURE;

EID: 33750442231     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl228     Document Type: Erratum

References (45)

1. Thomson,M. and Ali,M. (2003) Garlic [Allium sativum]: A review of its potential use as an anti-cancer agent. Curr. Cancer Drug Targets, 3, 67-81.
2. You,W.C., Blot,W.J., Chang,Y.S., Ershow,A., Yang,Z.T., An,Q., Henderson,B.E., Fraumeni,J.F.,Jr and Wang,T.G. (1989) Allium vegetables and reduced risk of stomach cancer. J. Natl Cancer Inst., 81, 162-164.
3. Hsing,A.W., Chokkalingam,A.P., Gao,Y.T., Madigan,M.P., Deng,J., Gridley,G. and Fraumeni,J.F. Jr (2002) Allium vegetables and risk of prostate cancer: A population-based study. J. Natl Cancer Inst., 94, 1648-1651.
4. Herman-Antosiewicz,A. and Singh,S.V. (2004) Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: A review. Mutat. Res., 555, 121-131.
5. Sundaram,S.G. and Milner,J.A. (1996) Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. J. Nutr., 126, 1355-1361.
6. Xiao,D., Choi,S., Johnson,D.E., Vogel,V.G., Johnson,C.S., Trump,D.L., Lee,Y.J. and Singh,S.V. (2004) Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2 Oncogene, 23, 5594-5606.
7. Xiao,D., Pinto,J.T., Soh,J.W., Deguchi,A., Gundersen,G.G., Palazzo,A.F., Yoon,J.T., Shirin,H. and Weinstein,I.B. (2003) Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res., 63, 6825-6837.
8. Giroldi,L.A. and Schalken,J.A. (1993) Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev., 12, 29-37.
9. Umbas,R., Isaacs,W.B., Bringuier,P.P., Schaafsma,H.E., Karthaus,H.F., Oosterhof,G.O., Debruyne,F.M. and Schalken,J.A. (1994) Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54, 3929-3933.
10. Umbas,R., Schalken,J.A., Aalders,T.W., Carter,B.S., Karthaus,H.F., Schaafsma,H.E., Debruyne,F.M. and Isaacs,W.B. (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52, 5104-5109.
11. Tsao,S.W., Liu,Y., Wang,X., Yuen,P.W., Leung,S.Y., Yuen,S.T., Pan,J., Nicholls,J.M., Cheung,A.L. and Wong,Y.C. (2003) The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur. J. Cancer, 39, 524-531.
12. Si,H.X., Tsao,S.W., Lam,K.Y., Srivastava,G., Liu,Y., Wong,Y.C., Shen,Z.Y. and Cheung,A.L. (2001) E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett., 173, 71-78.
13. Shirin,H., Pinto,J.T., Kawabata,Y., Soh,J.W., Delohery,T., Moss,S.F., Murty,V., Rivlin,R.S., Holt,P.R. and Weinstein,I.B. (2001) Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res., 61, 725-731.
14. Wang,X., Jin,D.Y., Wong,H.L., Feng,H., Wong,Y.C. and Tsao,S.W. (2003) MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells. Oncogene, 22, 109-116.
15. Albini,A., Iwamoto,Y., Kleinman,H.K., Martin,G.R., Aaronson,S.A., Kozlowski,J.M. and McEwan,R.N. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245.
16. Espineda,C.E., Chang,J.H., Twiss,J., Rajasekaran,S.A. and Rajasekaran,A.K. (2004) Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol. Biol. Cell, 15, 1364-1373.
17. Feng,H.C., Tsao,S.W., Ngan,H.Y., Xue,W.C., Chiu,P.M. and Cheung,A.N. (2005) Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia. Cancer, 104, 2409-2416.
18. Ji,X., Woodard,A.S., Rimm,D.L. and Fearon,E.R. (1997) Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ., 8, 773-778.
19. Hajra,K.M., Ji,X. and Fearon,E.R. (1999) Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene, 18, 7274-7279.
20. Thiery,J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
21. Yang,J., Mani,S.A., Donaher,J.L., Ramaswamy,S., Itzykson,R.A., Come,C., Savagner,P., Gitelman,I., Richardson,A. and Weinberg,R.A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939.
22. Takeichi,M. (1993) Cadherins in cancer: Implications for invasion and metastasis. Curr. Opin. Cell Biol., 5, 806-811.
23. Bracke,M.E., Van Roy,F.M. and Mareel,M.M. (1996) The E-cadherin/catenin complex in invasion and metastasis. Curr. Top. Microbiol. Immunol., 213, 123-161.
24. Birchmeier,W., Behrens,J., Weidner,K.M., Hulsken,J. and Birchmeier,C. (1996) Epithelial differentiation and the control of metastasis in carcinomas. Curr. Top. Microbiol. Immunol., 213, 117-135.
25. Morton,R.A., Ewing,C.M., Nagafuchi,A., Tsukita,S. and Isaacs,W.B. (1993) Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res., 53, 3585-3590.
26. Christofori,G. and Semb,H. (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci., 24, 73-76.
27. Aberle,H., Schwartz,H. and Kemler,R. (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell. Biochem., 61, 514-523.
28. Birchmeier,W. and Behrens,J. (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta, 1198, 11-26.
29. Vleminckx,K., Vakaet,L.,Jr, Mareel,M., Fiers,W. and Van,R.F. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
30. Frixen,U.H., Behrens,J., Sachs,M., Eberle,G., Voss,B., Warda,A., Lochner,D. and Birchmeier,W. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell. Biol., 113, 173-185.
31. Perl,A.K., Wilgenbus,P., Dahl,U., Semb,H. and Christofori,G. (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 392, 190-193.
32. Batlle,E., Sancho,E., Franci,C., Dominguez,D., Monfar,M., Baulida,J. and Garcia De,H.A. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2, 84-89.
33. Cano,A., Perez-Moreno,M.A., Rodrigo,I., Locascio,A., Blanco,M.J., del Barrio,M.G., Portillo,F. and Nieto,M.A. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2, 76-83.
34. Bussemakers,M.J., Giroldi,L.A., van,B.A. and Schalken,J.A. (1994) Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: Characterization of the human E-cadherin gene promoter. Biochem. Biophys. Res. Commun., 203, 1284-1290.
35. Giroldi,L.A., Bringuier,P.P., de,W.M., Jansen,C., van,B.A. and Schalken,J.A. (1997) Role of E boxes in the repression of E-cadherin expression. Biochem. Biophys. Res. Commun., 241, 453-458.
36. Miyoshi,A., Kitajima,Y., Sumi,K., Sato,K., Hagiwara,A., Koga,Y. and Miyazaki,K. (2004) Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br. J. Cancer, 90, 1265-1273.
37. Peinado,H., Portillo,F. and Cano,A. (2004) Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol., 48, 365-375.
38. Shiina,H., Breault,J.E., Basset,W.W. et al. (2005) Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res., 65, 2130-2138.
39. Bienz,M. (2005) beta-Catenin: A pivot between cell adhesion and Wnt signalling. Curr. Biol., 15, R64-R67.
40. Huber,A.H. and Weis,W.I. (2001) The structure of the β-catenin/ E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell, 105, 391-402.
41. Hulsken,J., Birchmeier,W. and Behrens,J. (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell. Biol., 127, 2061-2069.
42. von Kries,J.P., Winbeck,G., Asbrand,C., Schwarz-Romond,T., Sochnikova,N., Dell'Oro,A., Behrens,J. and Birchmeier,W. (2000) Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat. Struct. Biol., 7, 800-807.
43. Hazan,R.B., Kang,L., Roe,S., Borgen,P.I. and Rimin,D.L. (1997) Vinculin is associated with the E-cadherin adhesion complex. J. Biol. Chem., 272, 32448-32453.
44. Veveris-Lowe,T.L., Lawrence,M.G., Collard,R.L., Bui,L., Herington,A.C., Nicol,D.L. and Clements,J.A. (2005) Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr. Relat Cancer, 12, 631-643.
45. Sigounas,G., Hooker,J., Anagnostou,A. and Steiner,M. (1997) S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutr. Cancer, 27, 186-191.